Morgan Stanley »

Travere Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $20M 2.2M 8.94
2023-06-30 $12M 799k 15.36
2022-12-31 $15M 692k 21.02
2022-06-30 $14M 586k 22.99
2022-03-31 $13M 486k 25.77
2021-06-30 $2.0M 137k 14.59
2020-12-31 $1.6M 60k 27.26